We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $28.5B Turnover 25.57%
1-Year Est. Return 37.56%
 

Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.

This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+37.56%
3 Year Est. Return
+139.56%
5 Year Est. Return
+184.28%
10 Year Est. Return
+661.21%
AUM
$28.5B
AUM Growth
+$740M
Cap. Flow
+$898M
Cap. Flow %
3.15%
Top 10 Hldgs %
30.41%
Holding
1,052
New
118
Increased
279
Reduced
477
Closed
151
Avg Time Held
2.1 years
Top 10 Avg Time Held
4.1 years
Top 20 Avg Time Held
2.6 years

Top Buys

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$265M
2
CMI icon
Cummins
CMI
+$251M
3
F icon
Ford
F
+$188M
4
HUM icon
Humana
HUM
+$172M
5
MSFT icon
Microsoft
MSFT
+$167M

Sector Composition

Rank Sector Weight
1 Technology 34.64%
2 Financials 12.47%
3 Consumer Discretionary 12.33%
4 Industrials 11.08%
5 Healthcare 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
THRM icon
1026
Gentherm
THRM
$1.58B
– –
-81,300
Closed -$2.77M –
TRV icon
1027
Travelers Companies
TRV
$82.6B
– –
-11,651
Closed -$3.85M –
TT icon
1028
Trane Technologies
TT
$89.3B
– –
-43,486
Closed -$21.4M –
TTD icon
1029
Trade Desk
TTD
$7.01B
– –
-1,354,768
Closed -$24.5M –
TXRH icon
1030
Texas Roadhouse
TXRH
$12.2B
– –
-7,203
Closed -$1.39M –
TYRA icon
1031
Tyra Biosciences
TYRA
$1.38B
– –
-89,205
Closed -$2.85M –
ULTA icon
1032
Ulta Beauty
ULTA
$28.2B
– –
-4,763
Closed -$2.15M –
VIR icon
1033
Vir Biotechnology
VIR
$1.64B
– –
-136,335
Closed -$1.39M –
VLY icon
1034
Valley National Bancorp
VLY
$7.88B
– –
-418,113
Closed -$6.13M –
VREX icon
1035
Varex Imaging
VREX
$769M
– –
-479,785
Closed -$5M –
VSAT icon
1036
Viasat
VSAT
$9.43B
– –
-5,443
Closed -$489K –
VTEX icon
1037
VTEX
VTEX
$643M
– –
-111,316
Closed -$445K –
WABC icon
1038
Westamerica Bancorp
WABC
$1.36B
– –
-36,941
Closed -$2.17M –
WEAV icon
1039
DELISTED
Weave Communications
WEAV
– –
-1,073,822
Closed -$6.43M –
WHD icon
1040
Cactus
WHD
$4.83B
– –
-17,997
Closed -$922K –
WST icon
1041
West Pharmaceutical
WST
$29.1B
– –
-507,786
Closed -$182M –
XRAY icon
1042
Dentsply Sirona
XRAY
$1.78B
– –
-24,936
Closed -$265K –
ZETA icon
1043
Zeta Global
ZETA
$9.16B
– –
-72,581
Closed -$1.43M –
ZGN icon
1044
Zegna
ZGN
$3.79B
– –
-32,705
Closed -$426K –
BTSG icon
1045
BrightSpring Health Services
BTSG
$14.2B
– –
-12,432
Closed -$867K –
MGX icon
1046
Metagenomi Therapeutics
MGX
$26.2M
– –
-160,000
Closed -$190K –
PENG icon
1047
Penguin Solutions
PENG
$2.68B
– –
-83,668
Closed -$6.36M –
MAZE icon
1048
Maze Therapeutics
MAZE
$1.88B
– –
-65,468
Closed -$1.95M –
KRMN icon
1049
Karman Holdings
KRMN
$4.97B
– –
-49,355
Closed -$2.46M –
AVBH icon
1050
Avidbank Holdings
AVBH
$382M
– –
-13,270
Closed -$438K –

Similar funds

Jacobs Levy Equity Management's Q3 2026 Portfolio in Review

As of Q3 2026, Jacobs Levy Equity Management held 1,052 positions worth $28.5B, up 2.7% from $27.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jacobs Levy Equity Management deployed $898M of net new capital in Q3 2026, opening 118 new positions and adding to 279 existing holdings. Its largest new stake was Monster Beverage: 5,720,419 shares worth $238M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Atlassian, an estimated $158M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2026 buy was Monster Beverage: 5,720,419 shares worth $238M.
  • Jacobs Levy Equity Management added most to Cummins in Q3 2026, an estimated $251M increase.
  • Jacobs Levy Equity Management's biggest Q3 2026 reduction was Atlassian, cutting an estimated $158M.
  • Jacobs Levy Equity Management fully exited West Pharmaceutical in Q3 2026, selling an estimated $182M.
  • Jacobs Levy Equity Management's ten largest holdings make up 30% of its $28.5B portfolio in Q3 2026.
  • Jacobs Levy Equity Management opened 118 new positions and closed 151 in Q3 2026.
  • Jacobs Levy Equity Management's portfolio value rose 2.7% quarter-over-quarter to $28.5B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.